AL inhibitors are a class of chemical compounds that specifically target and inhibit the activity of enzymes or proteins categorized under the abbreviation "AL," which commonly refers to enzymes such as aldehyde dehydrogenases (ALDHs) or similar aldehyde-related proteins. These enzymes play a pivotal role in catalyzing the oxidation of aldehydes into carboxylic acids, which is a key step in various metabolic processes. AL inhibitors work by binding to the enzyme's active site or allosteric sites, preventing the enzyme from interacting with its natural substrates, typically aldehydes. The inhibitors are designed to mimic the structural characteristics of aldehydes or other substrate molecules, enabling them to compete effectively for the active site and disrupt the enzyme's catalytic function. AL inhibitors often contain chemical features like carbonyl groups or specific functional groups that interact with catalytic residues in the enzyme, forming stable interactions that block enzyme activity.
The development of AL inhibitors is based on extensive structural studies of the target enzyme, often using techniques like X-ray crystallography, nuclear magnetic resonance (NMR), or cryo-electron microscopy to determine the enzyme's three-dimensional structure and active site configuration. Understanding these structural details allows for the rational design of inhibitors that can selectively bind to AL enzymes without affecting other similar enzymes in metabolic pathways. Computational methods, such as molecular docking and dynamics simulations, are frequently used to predict how AL inhibitors interact with the enzyme and to optimize their binding affinity and specificity. In some cases, allosteric AL inhibitors may be developed to bind at locations distant from the active site, inducing conformational changes that inhibit enzyme activity indirectly. These inhibitors provide valuable tools for exploring the role of AL enzymes in metabolism and other biochemical processes, offering insight into the mechanisms that regulate aldehyde oxidation and associated pathways.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $50.00 $374.00 $2071.00 | 18 | |
Modulates the immune system and may reduce the production of abnormal light chains indirectly by affecting plasma cell function. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Alters multiple signaling pathways and may decrease the production of inflammatory cytokines affecting plasma cell survival. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor that can lead to apoptosis of plasma cells, potentially reducing the synthesis of light chains. | ||||||
Melphalan | 148-82-3 | sc-204799 sc-204799A | 100 mg 250 mg | $139.00 $242.00 | 5 | |
Alkylating agent that can damage the DNA of rapidly dividing cells, including plasma cells producing light chains. | ||||||
Cyclophosphamide | 50-18-0 | sc-361165 sc-361165A sc-361165B sc-361165C | 50 mg 100 mg 500 mg 1 g | $90.00 $146.00 $469.00 $791.00 | 18 | |
Another alkylating agent that targets proliferating cells and could decrease the production of abnormal light chains. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
A corticosteroid that can suppress inflammation and affect plasma cell proliferation and survival. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Interacts with DNA and inhibits RNA polymerase, reducing mRNA synthesis for various proteins, including light chains. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Blocks peptide elongation on ribosomes, inhibiting protein synthesis in eukaryotic cells broadly. | ||||||
Chlorambucil | 305-03-3 | sc-204682 sc-204682A | 250 mg 1 g | $52.00 $122.00 | 3 | |
Another DNA-alkylating agent that can impair cell division and function in lymphocytes, including plasma cells. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR signaling, which is important for cell growth and proliferation, affecting plasma cell function. | ||||||